Reunited emo rock band My Chemical Romance will play their biggest local show to date when they headline Target Field on Aug. 24.

Tickets go on sale at noon through Ticketmaster. Indie rock veterans Sleater-Kinney open.

Lead singer Gerard Way and drummer Matt Pelissier formed the band in New Jersey shortly after the Sept. 11 attacks. Way said seeing the World Trade Center towers fall made him realize “music was this thing I secretly wanted to do.” Way’s younger brother Mikey joined the group on bass and named them after Irvine Welsh’s novel “Ecstasy: Three Tales of Chemical Romance.”

After releasing their 2002 debut album “I Brought You My Bullets, You Brought Me Your Love” on an independent label, My Chemical Romance signed to Reprise Records. Thanks in large part to heavy touring, the band’s 2004 effort “Three Cheers for Sweet Revenge” went triple platinum, as did its follow-up “The Black Parade.”

My Chemical Romance made “The Black Parade” with Green Day producer Rob Cavallo and took a much more mainstream approach, earning many comparisons to Queen. For their next record, 2010’s “Danger Days: The True Lives of the Fabulous Killjoys,” the band embarked on an arena tour that brought them to the X in September 2011. Two years later, they broke up without citing any specific reasons.

Related Articles

Besides good music, Farm Aid 40 shines a light on Minnesota farmers and politics

Here’s what to know about the new Prince, Replacements and Hüsker Dü reissues

Live Reviews: At Farm Aid 40, an 18-act benefit concert visits MN for the first time

Music and food events abound this weekend in the Twin Cities

Joyce DiDonato is a thrilling partner as Minnesota Orchestra opens season

In 2019, the band announced they were reuniting for what fans thought was a one-off show that December at a Los Angeles theater. It sold out in four minutes and grossed $1.4 million. In January 2020, they revealed a full North American tour that sold out in less than six hours, but it was delayed several times due to the pandemic. The band finally hit the road in 2022 and sold out the venue formerly known as Xcel Energy Center that September.

This summer, My Chemical Romance sold more than 450,000 tickets to their stadium tour of 10 North American markets. As they did at those shows, the band will be playing “The Black Parade” in full during the 2026 tour.

After finishing the game for the Vikings on Sunday at U.S. Bank Stadium, rookie left guard Donovan Jackson flew to Los Angeles and underwent successful wrist surgery on Monday.

The announcement from head coach Kevin O’Connell came as a surprise externally because Jackson performed very well for the Vikings in the 48-10 win over the Cincinnati Bengals. It didn’t come as a surprise internally because Jackson actually suffered the injury last week in the 22-6 loss to the Atlanta Falcons.

“It was determined last week that he could play in the football game and not do any further harm,” O’Connell said. “I thought Donovan was fantastic on the field.”

As much as he praised Jackson for the toughness he displayed, O’Connell also made it clear that the Vikings felt it was important that he had wrist surgery so he’d be back to 100 percent sooner rather than later.

“I’m sure he would possibly try to fight through it and worry about everything later,” O’Connell said. “Sometimes we have to do what’s in the best interest of a really talented young player who we have really high aspirations for in the present and in the future.”

This isn’t expected to keep Jackson out long term. In fact, he won’t even be placed on injured reserve, which suggests that the Vikings believe he should be able to return within the next month or so.

As he works his way through the recovery process, Jackson will travel with his teammates across the pond, meaning he will be in attendance when the Vikings play the Pittsburgh Steelers in Dublin and the Cleveland Browns in London.

Though there isn’t a firm timeline as to when he will be back in action, O’Connell mentioned the bye week as a target, meaning Jackson might be ready to roll when the Vikings host the Philadelphia Eagles on Oct. 19.

In the absence of Jackson for at least the next couple of games, the Vikings will turn to veteran left guard Blake Brandel, who has familiarity in that spot, having played there last season.

As soon as Jackson is healthy, he will reassume that role on the starting offensive line.

“He’s off to a great start in his career,” O’Connell said. “Everything we hoped he would be.”

Briefly

After serving his suspension in full, receiver Jordan Addison has officially been reinstated. As a part of the process, the Vikings got a brief roster exemption. They will have to make a corresponding roster move on Wednesday at some point.

Related Articles

Takeaways from the Vikings’ 48-10 win over the Bengals

Shipley: Is it too early for a Vikings quarterback controversy?

Isaiah Rodgers leads Vikings to blowout win over Bengals

The Loop Fantasy Football Update Week 3: Last-minute moves

Harrison Smith and Christian Darrisaw returned for Vikings against Bengals

By TOM MURPHY

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition.

Related Articles

A jury will look at whether Amazon tricked customers into joining Prime — and made it hard to leave

Seattle, a coffee haven, is watching java prices spike. Why?

Spirit Airlines to furlough 1,800 flight attendants amid second bankruptcy

Compass to buy rival brokerage operator Anywhere Real Estate for about $1.5 billion

Nvidia to invest $100 billion in OpenAI to help expand the ChatGPT maker’s computing power

The COVID-19 vaccine and treatment maker said Monday that it will pay $47.50 in cash for each share of development-stage drugmaker Metsera. That represents a premium of more than 42% to Metsera’s closing price Friday.

Pfizer also could pay an additional $22.50 per share depending on how Metsera’s product pipeline develops.

Metsera Inc. has no products on the market, but its pipeline includes four programs in clinical development and one in mid-stage testing. Pfizer said the deal will add expertise and potential oral and injectable treatments.

Pfizer CEO Albert Bourla noted in a statement from the drugmaker that there are more than 200 health conditions associated with obesity, which he called “a large and growing space.”

Demand for obesity treatments has soared in recent years, due to unprecedented weight loss provided by regular injections of market leaders Wegovy from Novo Nordisk and Eli Lilly and Co.’s Zepbound. The Lilly drug generated $5.7 billion in sales in the first half of the year.

But the drugs can cost patients hundreds of dollars a month, and experts in the field are looking for competition to potentially drive down prices.

Pfizer currently has no obesity treatments on the market but has some in clinical development. Earlier this year, the company said it was ending development of a potential once-daily pill treatment before it started late-stage testing, the biggest and most expensive phase of clinical development.

Pfizer said the boards of both New York-based companies have approved the deal, but Metsera shareholders still need to OK it. The companies expect the acquisition to close in this year’s fourth quarter. It still needs approval from regulators.

Shares of Pfizer Inc. climbed 38 cents to $24.40 before markets opened Monday while Metsera’s stock advanced about 61%.

By MICHAEL KUNZELMAN

WASHINGTON (AP) — A man accused of shining a laser pointer at Marine One with President Donald Trump aboard the helicopter has been arrested on a federal criminal charge, according to a court filing on Monday.

Related Articles

Trump promotes unproven ties between Tylenol, vaccines and autism without new evidence

Trump administration wants to hand out $2.4 billion it took from California’s high-speed railroad

White House backs ‘border czar’ after reports he accepted cash during undercover FBI probe last year

Federal judge lifts Trump administration’s halt of nearly complete offshore wind farm in New England

Supreme Court will weigh expanding Trump’s power to shape agencies by overturning 90-year-old ruling

Jacob Samuel Winkler, 33, of Washington, D.C., is charged with aiming the beam of a laser pointer at an aircraft, a felony punishable by a maximum prison sentence of five years. Online court records don’t list an attorney representing him.

Marine One was airborne on Saturday near the White House when a U.S. Secret Service patrol officer spotted Winkler walking on a sidewalk, shirtless and loudly talking to himself, the officer wrote in an affidavit. The officer said he shone a flashlight at Winkler, who apparently retaliated by flashing a red laser beam at the officer’s face.

As Marine One flew over their heads, Winkler looked up and shined the laser pointer at the helicopter, according to the officer. After the officer handcuffed him, Winkler repeatedly talked about apologizing to Trump, the affidavit says.

The court filing doesn’t say if anybody aboard the helicopter noticed the laser. But the officer said Winkler’s conduct could have temporarily blinded or disoriented a pilot, placing Marine One at risk of an airborne collision with other helicopters in the area.

“This behavior endangers Marine One and everyone on board,” U.S. Attorney Jeanine Pirro said in a statement. “If you engage in this act, you will be identified and prosecuted to the fullest extent of the law.”

Winkler told investigators that he points the laser “at all kinds of things, such as stop signs,” and didn’t know he couldn’t point it at Marine One, the affidavit says. Investigators also found a small knife in his possession, according to the officer.